NNC4004-0002

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC4004-0002, covering 2025-09-24 to 2025-09-24. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia [Phase 1]

See pricing